Victory Capital Management’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.53M | Buy |
72,177
+62,915
| +679% | +$3.07M | ﹤0.01% | 1423 |
|
2025
Q1 | $472K | Buy |
9,262
+46
| +0.5% | +$2.34K | ﹤0.01% | 2048 |
|
2024
Q4 | $416K | Sell |
9,216
-227
| -2% | -$10.2K | ﹤0.01% | 2074 |
|
2024
Q3 | $350K | Sell |
9,443
-142
| -1% | -$5.27K | ﹤0.01% | 2097 |
|
2024
Q2 | $293K | Sell |
9,585
-114
| -1% | -$3.49K | ﹤0.01% | 2106 |
|
2024
Q1 | $282K | Sell |
9,699
-129
| -1% | -$3.75K | ﹤0.01% | 2137 |
|
2023
Q4 | $271K | Buy |
+9,828
| New | +$271K | ﹤0.01% | 2152 |
|
2023
Q3 | – | Sell |
-398,707
| Closed | -$16.2M | – | 2548 |
|
2023
Q2 | $16.2M | Buy |
398,707
+357,821
| +875% | +$14.6M | 0.02% | 852 |
|
2023
Q1 | $1.98M | Buy |
40,886
+21,350
| +109% | +$1.03M | ﹤0.01% | 1416 |
|
2022
Q4 | $746K | Sell |
19,536
-503
| -3% | -$19.2K | ﹤0.01% | 1869 |
|
2022
Q3 | $1.01M | Buy |
20,039
+12,021
| +150% | +$603K | ﹤0.01% | 1731 |
|
2022
Q2 | $321K | Sell |
8,018
-58
| -0.7% | -$2.32K | ﹤0.01% | 2213 |
|
2022
Q1 | $285K | Sell |
8,076
-152
| -2% | -$5.36K | ﹤0.01% | 2317 |
|
2021
Q4 | $328K | Sell |
8,228
-351
| -4% | -$14K | ﹤0.01% | 2352 |
|
2021
Q3 | $319K | Sell |
8,579
-413
| -5% | -$15.4K | ﹤0.01% | 2367 |
|
2021
Q2 | $380K | Sell |
8,992
-376
| -4% | -$15.9K | ﹤0.01% | 2330 |
|
2021
Q1 | $444K | Sell |
9,368
-6
| -0.1% | -$284 | ﹤0.01% | 2253 |
|
2020
Q4 | $572K | Buy |
9,374
+118
| +1% | +$7.2K | ﹤0.01% | 2014 |
|
2020
Q3 | $433K | Sell |
9,256
-340
| -4% | -$15.9K | ﹤0.01% | 2015 |
|
2020
Q2 | $487K | Sell |
9,596
-9,066
| -49% | -$460K | ﹤0.01% | 1992 |
|
2020
Q1 | $832K | Buy |
18,662
+8,613
| +86% | +$384K | ﹤0.01% | 1916 |
|
2019
Q4 | $483K | Buy |
10,049
+790
| +9% | +$38K | ﹤0.01% | 2029 |
|
2019
Q3 | $313K | Buy |
+9,259
| New | +$313K | ﹤0.01% | 2062 |
|